| Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF (NCT00458536) | Beth Israel Deaconess Medical Center | 2004-10-01 |
| Safety and Immunogenicity Study of LC16m8, a Modified Smallpox Vaccine, in Healthy, Previously Unvaccinated Volunteers (NCT00103584) | VaxGen | 2004-10-01 |
| The Effect of a Probiotic on Hepatic Steatosis (NCT00099723) | VSL Pharmaceuticals | 2004-10-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 1356 BS Administered to Healthy Male Subjects (NCT02173665) | Boehringer Ingelheim | 2004-10-01 |
| Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Laboratories Limited Under Fasting Condition (NCT01283919) | Dr. Reddy's Laboratories Limited | 2004-10-01 |
| Study Of SU011248 Plus Gefitinib (Iressa) In Patients With Advanced Renal Cell Carcinoma (NCT00113529) | Pfizer | 2004-10-01 |
| A Relative Bioavailability Study of Ramipril 10 mg Capsules Administered Orally as a Sprinkle on Applesauce (NCT00863915) | Actavis Inc. | 2004-10-01 |
| Study of Rapamycin Plus Ketoconazole in Advanced Cancers (NCT00708591) | University of Chicago | 2004-10-01 |
| A Pilot Study of Curcumin and Ginkgo for Treating Alzheimer's Disease (NCT00164749) | Chinese University of Hong Kong | 2004-10-01 |
| Efficacy of Music Therapy Protocols for Burn Debridement (NCT00822497) | MetroHealth Medical Center | 2004-10-01 |
| Adjunctive Donepezil Therapy and Genetic Risk Factors of Cognitive Dysfunction in Brain Tumor Survivors (NCT00594633) | Memorial Sloan Kettering Cancer Center | 2004-10-01 |
| Fed Study of Finasteride Tablets 5 mg and Proscar® Tablets 5 mg (NCT00650377) | Mylan Pharmaceuticals Inc | 2004-10-01 |
| Pilot Clinical Trial of Computer-based Motivational Intervention - 1 (NCT00230022) | Wayne State University | 2004-10-01 |
| A Double-blind, Randomised Study to Assess the Influence of Tiotropium (Spiriva®) (NCT00257452) | Boehringer Ingelheim | 2004-10-01 |
| Safety Study: Combined Modality Treatment for Non-Small Cell Lung Cancer (NCT00265603) | Atlantic Health System | 2004-10-01 |
| Galantamine Bioequivalence Study of Dr. Reddy's Under Fed Condition (NCT01372306) | Dr. Reddy's Laboratories Limited | 2004-10-01 |
| Bioequivalence Study of Nateglinide Tablets 120 mg of Dr. Reddy's Laboratories Limited Under Fed Condition (NCT01160029) | Dr. Reddy's Laboratories Limited | 2004-10-01 |
| Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of MYO-029 (NCT00563810) | Wyeth is now a wholly owned subsidiary of Pfizer | 2004-10-01 |
| Effect of Capecitabine on the Pharmacokinetics of BMS-247550 and BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced Malignancies (NCT00207129) | R-Pharm | 2004-10-01 |
| Trandolapril 4 mg Tablet Under Non-Fasting Conditions (NCT00840073) | Teva Pharmaceuticals USA | 2004-10-01 |
| Pilot Safety Study to Determine the Ability of the Protector Cap Jet Injector to Prevent Cross-Contamination (NCT00219453) | PATH | 2004-10-01 |
| Study Evaluating SKI-606 (Bosutinib) In Advanced Malignant Solid Tumors (NCT00195260) | Pfizer | 2004-10-01 |
| A Study to Evaluate the Tolerability and Pharmacokinetics of Two Single and Multiple High Dose Regimens of BIA 2-093 In Healthy Volunteers (NCT01879345) | Bial - Portela C S.A. | 2004-10-01 |
| GLP-1 - Regulatory Mechanism of Postprandial Glycemia (NCT00980083) | Ludwig-Maximilians - University of Munich | 2004-10-01 |
| Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis (NCT00111553) | Access to Advanced Health Institute (AAHI) | 2004-10-01 |
| Celecoxib Treatment for Lung Cancer (NCT00108186) | US Department of Veterans Affairs | 2004-10-01 |
| HuMax-CD20 in Chronic Lymphocytic Leukemia (NCT00093314) | GlaxoSmithKline | 2004-10-01 |
| A Phase I/II Study of Liposomal Doxorubicin (Doxil)/Melphalan/Bortezomib (Velcade) in Relapsed/Refractory Multiple Myeloma (NCT00516191) | University of California, San Francisco | 2004-10-01 |
| To Demonstrate the Relative Bioavailability Study of Ramipril 10 mg Capsules Under Non-Fasting Conditions (NCT00946621) | Sandoz | 2004-10-01 |
| Cell Therapy in Chronic Limb Ischemia (NCT00533104) | CHU de Reims | 2004-10-01 |
| Bioavailability Study of Tranylcypromine 10mg Tablets Under Fasting Conditions (NCT00653393) | Par Pharmaceutical, Inc. | 2004-10-01 |
| Tipifarnib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT00101296) | National Cancer Institute (NCI) | 2004-10-01 |
| Sorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney Function (NCT00118170) | National Cancer Institute (NCI) | 2004-10-01 |
| Feasibility Study of a Vaginal Ring for Delivery of TMC120 (Dapivirine) (NCT00700284) | International Partnership for Microbicides, Inc. | 2004-10-01 |
| Administration of Autologous Dendritic Cells (DCs) Infected With an Adenovirus Expressing Her-2 (NCT00197522) | Hamilton Health Sciences Corporation | 2004-10-01 |
| Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors (NCT00095940) | National Cancer Institute (NCI) | 2004-10-01 |
| Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Laboratories Limited Under Fed Condition (NCT01283932) | Dr. Reddy's Laboratories Limited | 2004-10-01 |
| Flavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia (NCT00101231) | National Cancer Institute (NCI) | 2004-10-01 |
| Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition (NCT01161147) | Dr. Reddy's Laboratories Limited | 2004-10-01 |
| A Study of the Potential Effects of Trimethoprim on the Pharmacokinetics of ER OROS Paliperidone (NCT00892541) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2004-10-01 |
| A Study to Investigate Biomarkers of Skin Androgenization Following Testosterone Administration (0000-015)(COMPLETED). (NCT00969163) | Merck Sharp & Dohme LLC | 2004-10-01 |
| PTK787/ZK222584 With Bevacizumab in Patients With Refractory and/or Advanced Malignancies (NCT00611793) | SCRI Development Innovations, LLC | 2004-10-01 |
| A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fasting Conditions (NCT00864448) | Actavis Inc. | 2004-10-01 |
| Use of Sodium Stibogluconate as a Treatment for Leishmaniasis (NCT00657618) | U.S. Army Medical Research and Development Command | 2004-10-01 |
| Lay Health Advisors for Sexually Transmitted Disease Prevention (NCT00207506) | Centers for Disease Control and Prevention | 2004-10-01 |
| Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin Lymphoma (NCT00438880) | Mayo Clinic | 2004-10-01 |
| Everolimus for Treating Pediatric Patients With Recurrent or Refractory Tumors (NCT00187174) | St. Jude Children's Research Hospital | 2004-10-01 |
| MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or Lymphomas (NCT00098891) | National Cancer Institute (NCI) | 2004-10-01 |
| Doxorubicin Hydrochloride and Alvocidib in Treating Patients With Metastatic or Recurrent Sarcoma That Cannot Be Removed By Surgery (NCT00098579) | National Cancer Institute (NCI) | 2004-10-01 |
| To Demonstrate the Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fasting Conditions (NCT00946465) | Sandoz | 2004-10-01 |
| Single Rising Dose Study of BI 201335 ZW in Healthy Male Subjects (NCT02182271) | Boehringer Ingelheim | 2004-10-01 |
| Effect of Gemfibrozil on Serum Glycosylphosphatidylinositol (GPI) Phospholipase D and Triglycerides (NCT00108511) | US Department of Veterans Affairs | 2004-10-01 |
| Study of D-Methadone in Patients With Chronic Pain (NCT00588640) | Memorial Sloan Kettering Cancer Center | 2004-10-01 |
| Vaccination of Melanoma Patients With Dendritic Cells Loaded With Allogeneic Apoptotic-Necrotic Melanoma Cells (NCT00515983) | José Mordoh, M.D., Ph.D. | 2004-10-01 |
| Study of Pharmacokinetic Interaction Between Combivir® (ZDV+3TC) and BILR 355 BS Plus Ritonavir in Healthy Subjects (NCT02256774) | Boehringer Ingelheim | 2004-10-01 |
| Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System (NCT00100087) | Theragenics Corporation | 2004-10-01 |
| Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer (NCT00486356) | University of Nebraska | 2004-10-01 |
| Phase 1-2 Vatalanib and Gemcitabine in Advanced Pancreatic Cancer (NCT00185588) | George Albert Fisher | 2004-10-01 |
| Study Of Safety And Tolerability Of GW786034 Given With Lapatinib In Cancer Patients (NCT00158782) | GlaxoSmithKline | 2004-09-28 |
| NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine (NCT00199849) | Ludwig Institute for Cancer Research | 2004-09-27 |
| Use of Busulfan as Conditioning Agent for a Second Stem Cell Transplant (NCT00092937) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-09-23 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GRT9906 Prolonged Release Tablets After Dose Escalation in Healthy Subjects (NCT03776110) | Grünenthal GmbH | 2004-09-15 |
| Open-Label Extension Study Evaluating Long Term Safety in Patients With Type 1 Gaucher Disease Receiving DRX008A (ERT) (NCT00391625) | Shire | 2004-09-13 |
| Anthrax Vaccine Clinical Trials (NCT00114621) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2004-09-08 |
| Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer (NCT00317772) | M.D. Anderson Cancer Center | 2004-09-02 |
| Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors (NCT00093821) | National Cancer Institute (NCI) | 2004-09-01 |
| Dendritic Cell Based Therapy of Renal Cell Carcinoma (NCT00197860) | Inge Marie Svane | 2004-09-01 |
| A Study to Assess the Effect of SB 659032 on Platelet Function (NCT01750827) | GlaxoSmithKline | 2004-09-01 |
| Effect of Progesterone on Smoking Behavior in Male and Female Smokers (NCT00271206) | Yale University | 2004-09-01 |
| To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Non-Fasting Conditions (NCT00947128) | Sandoz | 2004-09-01 |
| Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Esophageal Cancer (NCT00238147) | University of Washington | 2004-09-01 |
| Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy (NCT00222443) | University of Oklahoma | 2004-09-01 |
| Effectiveness of a Vitamin Mineral Supplement (NCT00153764) | The Cooper Institute | 2004-09-01 |
| Valacyclovir 1000 mg Tablet Under Fed Conditions (NCT01149460) | Teva Pharmaceuticals USA | 2004-09-01 |
| Vitamin K Injections for the Treatment of Painful Menstruation (NCT00104546) | National Center for Complementary and Integrative Health (NCCIH) | 2004-09-01 |
| Study of mAb 216 With Chemotherapy for Treatment of Pediatric Relapsed or Refractory B-progenitor Acute Lymphoblastic Leukemia (NCT00313053) | Clare Twist | 2004-09-01 |
| To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Fasting Conditions (NCT00946387) | Sandoz | 2004-09-01 |
| Study of Multiple Oral Doses of Odanacatib (MK0822) in Healthy Adults (0822-002) (NCT00769418) | Merck Sharp & Dohme LLC | 2004-09-01 |
| Dendritic Cell Based Therapy of Metastatic Breast Cancer (NCT00197925) | Herlev Hospital | 2004-09-01 |
| Bioequivalence Study of Ibuprofen 200 mg + Pseudoephedrine HCL 30 mg Tablets Under Fed Conditions (NCT01132222) | Dr. Reddy's Laboratories Limited | 2004-09-01 |
| Pharmacokinetic & Pharmacodynamic Study of ABT-751 With Carboplatin in Patients With Advanced Lung Cancer (NCT00735878) | Konstantin Dragnev | 2004-09-01 |
| Safety and Efficacy of an Immune Response Modifier to Treat Inoperable Advanced Melanoma Skin Lesions (NCT00091689) | Pfizer | 2004-09-01 |
| Preliminary Testing of New Treatment for Chronic Leg Wounds (NCT01858272) | University of Pennsylvania | 2004-09-01 |
| New Options for Preoperative Anesthesia in Intrauterine Needling (NCT01013558) | Leiden University Medical Center | 2004-09-01 |
| Sensor Measurement of Acupuncture Needle Manipulation (NCT00103675) | National Center for Complementary and Integrative Health (NCCIH) | 2004-09-01 |
| Safety of and Immune Response to Two HIV Vaccine Formulations (rMVA-HIV and rFPV-HIV) Alone or in Combination in HIV Uninfected Adults (NCT00083603) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-09-01 |
| Folate-Depleted Diet Compared With Folate-Supplemented Diet in Preventing Colorectal Cancer in Patients at High Risk for Colorectal Cancer (NCT00096330) | Roswell Park Cancer Institute | 2004-09-01 |
| To Assess the Safety and Tolerability of 7.5, 15 and 30 mg of Sublingual Lobeline. - 1 (NCT00100074) | National Institute on Drug Abuse (NIDA) | 2004-09-01 |
| A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer (NCT00141297) | Pfizer | 2004-09-01 |
| Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma (NCT00580320) | Virginia Commonwealth University | 2004-09-01 |
| Early Versus Delayed Pneumococcal Vaccination in HIV (NCT00137605) | CIHR Canadian HIV Trials Network | 2004-09-01 |
| An Affect Management Intervention for Juvenile Offenders (NCT00748800) | Rhode Island Hospital | 2004-09-01 |
| TNF-Alpha Inhibition for Treatment of Alzheimer's Disease (NCT00203359) | Tobinick, Edward Lewis, M.D. | 2004-09-01 |
| Short-course Hypofractionated Radiotherapy for Localized Prostate Cancer (NCT00126165) | Alberta Health services | 2004-09-01 |
| Development of Human Laboratory Study Model of Cocaine Relapse Prevention II - 1 (NCT00094315) | National Institute on Drug Abuse (NIDA) | 2004-09-01 |
| Study of HuMax-CD20, a New Drug to Treat Early Stage Non-Hodgkin´s Follicular Lymphoma (NCT00092274) | GlaxoSmithKline | 2004-09-01 |
| MAD in Cancer Patients: Safety of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors (NCT00207103) | Bristol-Myers Squibb | 2004-09-01 |
| Safety of KAI-9803 for Injection With Angioplasty Following Heart Attack (NCT00093197) | KAI Pharmaceuticals | 2004-09-01 |
| Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid Leukemia (NCT00096122) | National Cancer Institute (NCI) | 2004-09-01 |
| Human Safety of Capsaicin Inhalation Challenge Testing for Young and Older Men (NCT01621685) | University of South Florida | 2004-09-01 |